Envi™-SR Randomized Controlled Trial for Endovascular Treatment of Ischemic Stroke
NCT: NCT05107206 · TERMINATED
Реклама
NCT IDNCT05107206
СтатусTERMINATED
Дата начала2022-06-23
Завершение2025-01-27
Краткое описание
The study objective is to examine and compare clinical outcomes, as measured by Modified Rankin Scale (mRS) at 90 days (± 15 days) post treatment, and related performance characteristics of the Envi™-SR and concurrent parallel Control Devices currently cleared by the U.S. FDA for treatment of stroke.
Официальный источник
Открыть на ClinicalTrials.gov →Данные получены через API ClinicalTrials.gov. Актуальный статус смотрите в официальной записи.